MENU
PHVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pharvaris (PHVS) Ownership - Who owns Pharvaris?

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks... Show more

Profile

Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
65
Web
https://www.pharvaris.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.68B
P/E Ratio
N/A
Total Cash
329.29M
Projected Growth
N/A
Total Debt
578.66K
Revenue
N/A
Risk (Beta)
-6.40
Dividend Yield
N/A
Total Cash/Share
5.07
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PHVS
Capitalization
1.68B
P/E Ratio
N/A
Risk (Beta)
-6.40
Dividend Yield
N/A
Total Cash
329M
Total Cash/Share
5.07
Total Debt
579K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
312M
P/B Ratio
4.57
Cash Flow
N/A
Earnings
-2.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.8M
Current Ratio
12.86
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-166.91M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.22
Shares Held By Institutions
186M
Shares Outstanding - Current
65M
Total Liabilities
26.7M
Total Volume MTD
N/A
Value
1
Gain YTD
34.846
View a ticker or compare two or three
PHVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHVS showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
65
Web
https://www.pharvaris.com